Kara Gavin

For 100 years after the dawn of medical care at the University of Michigan, patients who wanted to have their ailments treated by the university’s illustrious physicians had to come to downtown Ann Arbor.

Lost jobs and wages due to COVID-19 mean a lack of health insurance and access to healthcare for many, but lower-cost options are available if you look.

For people with OCD, or obsessive compulsive disorder, a new brain imaging study may help personalize treatment including exposure therapy.

A new study shows the need for faster in-hospital testing for coronavirus (COVID-19) and other bacterial infections, which could reduce overuse of antibiotics.

Data from National Poll on Healthy Aging show reliance on delivery of medications, often because of insurance requirements.

Even before COVID-19 struck, general practitioners faced unsustainable demands; the pandemic offers a chance to change.

From opioids and antipsychotics to antidepressants and anxiety medicines, study looks at prescriptions among community-dwelling older adults with dementia.

Telehealth visits by older adults increased dramatically during the first months of the COVID-19 pandemic, yet some adults still have concerns about telemedicine and some face barriers.

People with high-deductible health plans aren’t using health savings account option as intended.

The University Hospital that served as U-M's main inpatient facility from 1925 to 1986 was an architectural marvel and drew patients from far and wide.

Convalescent plasma has shown promise against COVID-19, but new research will try to prove if it really works.

Lessons from early peak state of Michigan could inform hospitals in other areas.

History is all around us on the main Michigan Medicine campus. Which isn’t surprising, given that our Medical School opened in 1850 and our first hospital admitted its first patients in late 1869 -- the first university-owned hospital in the country.

A team of Michigan Medicine, University of Pittsburgh, Medical University of South Carolina and Stanford Medicine researchers were recently awarded funds from the National Heart, Lung, and Blood Institute (NHLBI)(link is external) in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), totaling more than $7 million to collaboratively study the role of convalescent plasma in mitigating symptoms of COVID-19 in patients with mild illness and preventing the progression of the disease from mild to severe.

Two new programs that harness advanced technology and the expertise of Michigan Medicine’s care teams could help patients avoid or shorten a hospital stay, while still getting the care they need.